Milestone Pharmaceuticals to Present at Upcoming Investor Conferences
Milestone Pharmaceuticals (Nasdaq: MIST) announced that Joseph Oliveto, President and CEO, will present at two key investor conferences.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Milestone Pharmaceuticals (Nasdaq: MIST) announced that Joseph Oliveto, President and CEO, will present at two key investor conferences. The first is the H.C. Wainwright & Co. 22nd Annual Global Investment Conference on September 15, 2020, at 11:30 a.m. ET. The second is the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit on September 23, 2020, at 2:30 p.m. ET. Live webcasts of the presentations will be available on Milestone's website, with archived replays accessible for 30 days post-event.
Details
News Market Reaction – MIST
The recorded move for MIST in the trading session of this news was -0.26%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
MONTREAL and CHARLOTTE, N.C., Sept. 8, 2020 /PRNewswire/ -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today announced that Joseph Oliveto, President and Chief Executive Officer, will present at the following investor conferences:
- The H.C. Wainwright & Co. 22nd Annual Global Investment Conference on Tuesday, September 15, 2020 at 11:30 a.m. Eastern Time
- The Oppenheimer Fall Healthcare Life Sciences & MedTech Summit on Wednesday, September 23, 2020 at 2:30 p.m. Eastern Time
A live webcast of the presentations can be accessed in the News & Events section of Milestone's website at www.milestonepharma.com. An archived replay of the webcasts will be available on the same website for approximately 30 days following the presentations.
About Milestone Pharmaceuticals
Milestone Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines. Milestone Pharmaceuticals operates in Canada and the United States. For more information, visit www.milestonepharma.com and follow the Company on Twitter at @MilestonePharma.
Contact
David Pitts
Argot Partners
212-600-1902
david@argotpartners.com
View original content to download multimedia:http://www.prnewswire.com/news-releases/milestone-pharmaceuticals-to-present-at-upcoming-investor-conferences-301124643.html
SOURCE Milestone Pharmaceuticals, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.